Skip to main content

Table 1 Selected population characteristics of bladder cancer cases and matched controls

From: Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2genes and bladder cancer risk in men and women

Variable

NHS

HPFS

 

Cases (n = 78)

Controls (n = 234)

P-value

Cases (n = 139)

Controls (n = 293)

P-value

Age at diagnosis (years),1 mean (SD)

60.6 (9.2)

60.6 (9.2)

> 0.99

68.5 (8.6)

68.6 (8.6)

0.87

BMI at diagnosis (kg), mean (SD)

22.0 (9.7)

23.8 (8.6)

0.13

25.8 (2.8)

25.5 (3.2)

0.45

Ethnicity/ancestry, n (%)

  

0.67

  

0.56

   Caucasian

65 (90.3)

210 (93.8)

 

128 (99.2)

275 (98.9)

 

   African-American

2 (2.8)

3 (1.3)

 

0 (0.0)

0 (0.0)

 

   Asian

0 (0.0)

1 (0.45)

 

0 (0.0)

0 (0.0)

 

   Hispanic

1 (1.4)

2 (0.89)

 

0 (0.0)

0 (0.0)

 

   Other

4 (5.6)

8 (3.6)

 

1 (0.78)

3 (1.1)

 

Packyears at diagnosis2, mean (SD)

30.2 (22.3)

27.6 (23.1)

0.49

30.9 (19.8)

26.9 (19.0)

0.14

Alcohol use at diagnosis (g), mean (SD)

6.3 (9.3)

6.1 (10.8)

0.86

16.1 (19.4)

13.2 (15.2)

0.12

Smoking status at diagnosis, n (%)

  

0.12

  

0.81

   Never

22 (29.7)

72 (31.0)

 

38 (31.9)

83 (32.1)

 

   Former

37 (50.0)

127 (54.7)

 

67 (56.3)

143 (55.2)

 

   Current

15 (20.3)

33 (14.2)

 

14 (11.8)

33 (12.7)

 
  1. 1 Cases and controls were matched on year of birth
  2. 2 Among cigarette smokers